SNS Insider Unveils Strategic Insights into the U.S. Breast Imaging Market Growth, Worth USD 1.60 Billion in 2023, While the U.S. Retains Global Leadership with Advanced Screening Technologies and ...

The success of clinical trials in Wilms' tumor over the past 30 years has led to an overall survival of 85%, and treatment-related morbidity has been reduced with less aggressive chemotherapeutic ...